Active substance
Succinylcholine
- SFDA 1
- US FDA 35
- Health Canada 3
- Safety 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LYSTHENON SICCUM VIAL | 500 mg | Solution · Intravenous use | 10 Ampoule | SAR 119.45 | NCE · Prescription | Takeda Manufacturing Austria AG | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ANECTINE | 20MG/ML | injectable · injection | SANDOZ | Prescription | 20 Aug 1952 |
| QUELICIN | 20MG/ML | injectable · injection | HOSPIRA | Prescription | 1 May 1953 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | ZYDUS PHARMS | Prescription | 4 May 2018 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | J MOLNER | Prescription | 4 Jun 2018 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | DR REDDYS | Prescription | 2 Aug 2019 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | SOMERSET THERAPS LLC | Prescription | 15 Jan 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | ASPIRO | Prescription | 4 May 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | NIVAGEN | Prescription | 19 May 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | REGCON HOLDINGS | Prescription | 22 May 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | HIKMA | Prescription | 12 Jun 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | GLAND | Prescription | 16 Jun 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 20 Nov 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | MICRO LABS | Prescription | 24 Nov 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | DEVA HOLDING AS | Prescription | 21 Dec 2020 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | SAGENT PHARMS INC | Prescription | 29 Mar 2021 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | MEITHEAL | Prescription | 19 Oct 2021 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | BE PHARMS | Prescription | 7 Feb 2022 |
| SUCCINYLCHOLINE CHLORIDE | 100MG/5ML (20MG/ML) | solution · intramuscular, intravenous | DR REDDYS | Prescription | 17 Jan 2024 |
| SUCCINYLCHOLINE CHLORIDE | 100MG/5ML (20MG/ML) | solution · intramuscular, intravenous | STERISCIENCE | Prescription | 9 Jul 2024 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | BAXTER HLTHCARE CORP | Prescription | 24 Sep 2024 |
| SUCCINYLCHOLINE CHLORIDE | 100MG/5ML (20MG/ML) | solution · intramuscular, intravenous | FRESENIUS KABI USA | Prescription | 11 Feb 2025 |
| SUCCINYLCHOLINE CHLORIDE | 20MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 21 Feb 2025 |
| ANECTINE | 500MG/VIAL; 50MG/ML; 1GM/VIAL | injectable · injection | SANDOZ | Discontinued | 20 Aug 1952 |
| SUCOSTRIN | 20MG/ML; 100MG/ML | injectable · injection | APOTHECON | Discontinued | 24 Apr 1953 |
| QUELICIN PRESERVATIVE FREE | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | HOSPIRA | Discontinued | 1 May 1953 |
10 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| QUELICIN | 00038172 | 20 MG / ML | SOLUTION · INTRAVENOUS | PFIZER CANADA ULC |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 02422336 | 20 MG / ML | SOLUTION · INTRAVENOUS | HIKMA CANADA LIMITED |
| SUCCINYLCHOLINE CHLORIDE INJECTION, USP | 02501783 | 20 MG / ML | SOLUTION · INTRAVENOUS | DR REDDY'S LABORATORIES LTD |
Safety signals and safety-related labeling changes
- US FDA 1 Nov 2022 ANECTINE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions - US FDA 1 Nov 2022 QUELICIN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations - US FDA 1 Nov 2022 SUCCINYLCHOLINE CHLORIDE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.